Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine vs Triclofos for EEG Sedation in Autism
NCT04270708Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine in Autism Spectrum Disorder (ASD), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04270708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270708.